STERIS Plc (Ireland) (STE)
257.40
+2.64
(+1.04%)
USD |
NYSE |
Nov 20, 11:41
STERIS Free Cash Flow : 937.20M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 937.20M |
| June 30, 2026 | 925.70M |
| March 31, 2026 | 972.40M |
| December 31, 2025 | 917.10M |
| September 30, 2025 | 958.89M |
| June 30, 2025 | 906.42M |
| March 31, 2025 | 775.68M |
| December 31, 2024 | 749.09M |
| September 30, 2024 | 680.11M |
| June 30, 2024 | 594.08M |
| March 31, 2024 | 612.95M |
| December 31, 2023 | 593.99M |
| September 30, 2023 | 535.44M |
| June 30, 2023 | 493.69M |
| March 31, 2023 | 394.98M |
| December 31, 2022 | 349.06M |
| September 30, 2022 | 398.59M |
| June 30, 2022 | 471.79M |
| March 31, 2022 | 379.78M |
| December 31, 2021 | 384.71M |
| September 30, 2021 | 370.26M |
| June 30, 2021 | 394.07M |
| March 31, 2021 | 437.53M |
| December 31, 2020 | 472.46M |
| September 30, 2020 | 398.26M |
| Date | Value |
|---|---|
| June 30, 2020 | 382.48M |
| March 31, 2020 | 374.76M |
| December 31, 2019 | 338.73M |
| September 30, 2019 | 346.98M |
| June 30, 2019 | 335.79M |
| March 31, 2019 | 349.30M |
| December 31, 2018 | 324.92M |
| September 30, 2018 | 314.42M |
| June 30, 2018 | 321.07M |
| March 31, 2018 | 292.18M |
| December 31, 2017 | 288.30M |
| September 30, 2017 | 278.46M |
| June 30, 2017 | 250.39M |
| March 31, 2017 | 251.18M |
| December 31, 2016 | 282.95M |
| September 30, 2016 | 203.36M |
| June 30, 2016 | 155.59M |
| March 31, 2016 | 128.27M |
| December 31, 2015 | 74.83M |
| September 30, 2015 | 131.95M |
| June 30, 2015 | 155.33M |
| March 31, 2015 | 160.78M |
| December 31, 2014 | 154.32M |
| September 30, 2014 | 158.71M |
| June 30, 2014 | 135.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Medtronic Plc | 6.132B |
| Trinity Biotech Plc | -12.50M |
| IDEXX Laboratories, Inc. | 1.296B |
| ResMed, Inc. | 1.588B |
| Alkermes Plc | 227.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 288.90M |
| Cash from Investing (Quarterly) | -76.10M |
| Cash from Financing (Quarterly) | -163.50M |
| Free Cash Flow Per Share (Quarterly) | 2.180 |
| Free Cash Flow to Equity (Quarterly) | 207.70M |
| Free Cash Flow to Firm (Quarterly) | 221.13M |
| Free Cash Flow Yield | 3.75% |